Share on LinkedInShare on LinkedIn

ARTICLE · 04 MARCH 2021

Russia, February 2021: Update On Pharma Regulatory Issues (Video)

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

On December 15, 2020, in the first reading, the Russian State Duma approved amendments to Article 1360 of the Civil Code "Use of an Invention, Utility Model or Industrial Design in the Interests of...

RussiaIntellectual Property

Use of patents without authorization of the right holder

On December 15, 2020, in the first reading, the Russian State Duma approved amendments to Article 1360 of the Civil Code "Use of an Invention, Utility Model or Industrial Design in the Interests of National Security" ("Amendments to Article 1360").

Transcript

Veronica: Hello. We would like to provide you with an update on Pharma regulatory issues in Russia. First we will speak about the recent government regulations related to use of patent with no consent of the right holders. Just to remind you, Russia is a member of the Eurasian Union and a part of a single pharmaceutical market. The circulation of medicines in Russia is therefore regulated by national laws and by special regional laws. At the same time, due to COVID-19 pandemic, the importance of national regulation by President and government have raised laws. On December 31st, 2020, our Russian government issued the order which allowed a

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from